|
1
|
Naito Y, Yoshioka Y, Yamamoto Y and Ochiya
T: How cancer cells dictate their microenvironment: Present roles
of extracellular vesicles. Cell Mol Life Sci. 74:697–713. 2017.
View Article : Google Scholar :
|
|
2
|
Dachs GU and Chaplin DJ:
Microenvironmental control of gene expression: Implications for
tumor angiogenesis, progression, and metastasis. Semin Radiat
Oncol. 8:208–216. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Whiteside TL: Exosome and mesenchymal stem
cell cross-talk in the tumor microenvironment. Semin Immunol.
35:69–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chou J, Shahi P and Werb Z:
microRNA-mediated regulation of the tumor microenvironment. Cell
Cycle. 12:3262–3271. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X, Wu Z, Fu X and Han W: A microRNA
component of the neoplastic Microenvironment: microregulators with
far-reaching impact. Biomed Res Int. 2013:7621832013.PubMed/NCBI
|
|
7
|
Zhang Y, Yang P and Wang XF:
Microenvironmental regulation of cancer metastasis by miRNAs.
Trends Cell Biol. 24:153–160. 2014. View Article : Google Scholar
|
|
8
|
Xu SJ, Hu HT, Li HL and Chang S: The role
of miRNAs in immune cell development, immune cell activation, and
tumor immunity: With a focus on macrophages and natural killer
cells. Cells. 8:pii: E1140. 2019. View Article : Google Scholar
|
|
9
|
Musumeci M, Coppola V, Addario A, Patrizii
M, Maugeri-Saccà M, Memeo L, Colarossi C, Francescangeli F, Biffoni
M, Collura D, et al: Control of tumor and microenvironment
cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene.
30:4231–4242. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review EMBO Mol Med. 9:8522017. View Article : Google Scholar
|
|
11
|
Que KT, Zhou Y, You Y, Zhang Z, Zhao XP,
Gong JP and Liu ZJ: MicroRNA-31-5p regulates chemosensitivity by
preventing the nuclear location of PARP1 in hepatocellular
carcinoma. J Exp Clin Cancer Res. 37:2682018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar
|
|
14
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar
|
|
15
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Corsini LR, Bronte G, Terrasi M, Amodeo V,
Fanale D, Fiorentino E, Cicero G, Bazan V and Russo A: The role of
microRNAs in cancer: Diagnostic and prognostic biomarkers and
targets of therapies. Expert Opin Ther Targets. 16(Suppl 2):
S103–S109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nana-Sinkam SP and Croce CM: Clinical
applications for microRNAs in cancer. Clin Pharmacol Ther.
93:98–104. 2013. View Article : Google Scholar
|
|
18
|
Pichler M and Calin GA: MicroRNAs in
cancer: From developmental genes in worms to their clinical
application in patients. Br J Cancer. 113:569–573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Soon P and Kiaris H: MicroRNAs in the
tumour microenvironment: Big role for small players. Endocr Relat
Cancer. 20:R257–R267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvi-ronment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuninty PR, Schnittert J, Storm G and
Prakash J: MicroRNA targeting to modulate tumor microenvironment.
Front Oncol. 6:32016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fanini F and Fabbri M: Cancer-derived
exosomic microRNAs shape the immune system within the tumor
microenvironment: State of the art. Semin Cell Dev Biol. 67:23–28.
2017. View Article : Google Scholar :
|
|
23
|
Curtale G: MiRNAs at the crossroads
between innate immunity and cancer: Focus on macrophages. Cells.
7:pii: E12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bandini E, Rossi T, Gallerani G and Fabbri
F: Adipocytes and microRNAs crosstalk: A key tile in the mosaic of
breast cancer microenvironment. Cancers (Basel). 11:pii: E1451.
2019. View Article : Google Scholar
|
|
25
|
Aprelikova O, Yu X, Palla J, Wei BR, John
S, Yi M, Stephens R, Simpson RM, Risinger JI, Jazaeri A and
Niederhuber J: The role of miR-31 and its target gene SATB2 in
cancer-associated fibroblasts. Cell Cycle. 9:4387–4398. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang M, Zhao C, Shi H, Zhang B, Zhang L,
Zhang X, Wang S, Wu X, Yang T, Huang F, et al: Deregulated
microRNAs in gastric cancer tissue-derived mesenchymal stem cells:
Novel biomarkers and a mechanism for gastric cancer. Br J Cancer.
110:1199–1210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Lai L, Chen Q, Song Y, Xu S, Ma F,
Wang X, Wang J, Yu H, Cao X and Wang Q: MicroRNA-494 is required
for the accumulation and functions of tumor-expanded
myeloid-derived suppressor cells via targeting of PTEN. J Immunol.
188:5500–5510. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Erez N, Truitt M, Olson P, Arron ST and
Hanahan D: Cancer-associated fibroblasts are activated in incipient
neoplasia to orchestrate tumor-promoting inflammation in an
NF-kappaB-dependent manner. Cancer Cell. 17:135–147. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bronisz A, Godlewski J, Wallace JA,
Merchant AS, Nowicki MO, Mathsyaraja H, Srinivasan R, Trimboli AJ,
Martin CK, Li F, et al: Reprogramming of the tumour
microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol.
14:159–167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baroni S, Romero-Cordoba S, Plantamura I,
Dugo M, D’Ippolito E, Cataldo A, Cosentino G, Angeloni V, Rossini
A, Daidone MG and Iorio MV: Exosome-mediated delivery of miR-9
induces cancer-associated fibroblast-like properties in human
breast fibroblasts. Cell Death Dis. 7:pp. e23122016, View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mitra AK, Zillhardt M, Hua Y, Tiwari P,
Murmann AE, Peter ME and Lengyel E: MicroRNAs reprogram normal
fibroblasts into cancer-associated fibroblasts in ovarian cancer.
Cancer Discov. 2:1100–1108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang X, Hou Y, Yang G, Wang X, Tang S, Du
YE, Yang L, Yu T, Zhang H, Zhou M, et al: Stromal miR-200s
contribute to breast cancer cell invasion through CAF activation
and ECM remod-eling. Cell Death Differ. 23:132–145. 2016.
View Article : Google Scholar
|
|
34
|
Du YE, Tu G, Yang G, Li G, Yang D, Lang L,
Xi L, Sun K, Chen Y, Shu K, et al: MiR-205/YAP1 in activated
fibroblasts of breast tumor promotes VEGF-independent angiogenesis
through STAT3 signaling. Theranostics. 7:3972–3988. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pang W, Su J, Wang Y, Feng H, Dai X, Yuan
Y, Chen X and Yao W: Pancreatic cancer-secreted miR-155 implicates
in the conversion from normal fibroblasts to cancer-associated
fibroblasts. Cancer Sci. 106:1362–1369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dror S, Sander L, Schwartz H, Sheinboim D,
Barzilai A, Dishon Y, Apcher S, Golan T, Greenberger S, Barshack I,
et al: Melanoma miRNA trafficking controls tumour primary niche
formation. Nat Cell Biol. 18:1006–1017. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen H, Yu X, Yang F, Zhang Z, Shen J, Sun
J, Choksi S, Jitkaew S and Shu Y: Reprogramming of normal
fibroblasts into cancer-associated fibroblasts by miRNAs-mediated
CCL2/VEGFA signaling. PLoS Genet. 12:e10062442016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu M, Wang M, Yang F, Tian Y, Cai J, Yang
H, Fu H, Mao F, Zhu W, Qian H and Xu W: miR-155-5p inhibition
promotes the transition of bone marrow mesenchymal stem cells to
gastric cancer tissue derived MSC-like cells via NF-κB p65
activation. Oncotarget. 7:16567–16580. 2016.PubMed/NCBI
|
|
39
|
Sung SY, Liao CH, Wu HP, Hsiao WC, Wu IH,
Jinpu Yu, Lin SH and Hsieh CL: Loss of let-7 microRNA upregulates
IL-6 in bone marrow-derived mesenchymal stem cells triggering a
reactive stromal response to prostate cancer. PLoS One. 8:pp.
e716372013, View Article : Google Scholar : PubMed/NCBI
|
|
40
|
De Veirman K, Wang J, Xu S, Leleu X, Himpe
E, Maes K, De Bruyne E, Van Valckenborgh E, Vanderkerken K, Menu E
and Van Riet I: Induction of miR-146a by multiple myeloma cells in
mesenchymal stromal cells stimulates their protumoral activity.
Cancer Lett. 377:17–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Horiguchi H, Kobune M, Kikuchi S, Yoshida
M, Murata M, Murase K, Iyama S, Takada K, Sato T, Ono K, et al:
Extracellular vesicle miR-7977 is involved in hematopoietic
dysfunction of mesenchymal stromal cells via poly(rC) binding
protein 1 reduction in myeloid neoplasms. Haematologica.
101:437–447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jang JY, Lee JK, Jeon YK and Kim CW:
Exosome derived from epigallocatechin gallate treated breast cancer
cells suppresses tumor growth by inhibiting tumor-associated
macrophage infiltration and M2 polarization. BMC Cancer.
13:4212013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu Z, Zhao L, Zhu LY, He M, Zheng L and Wu
Y: MicroRNA-17, 20a regulates the proangiogenic function of
tumor-associated macrophages via targeting hypoxia-inducible factor
2α. PLoS One. 8:pp. e778902013, View Article : Google Scholar
|
|
44
|
Lagrange B, Martin RZ, Droin N, Aucagne R,
Paggetti J, Largeot A, Itzykson R, Solary E, Delva L and Bastie JN:
A role for miR-142-3p in colony-stimulating factor 1-induced
monocyte differentiation into macrophages. Biochim Biophys Acta.
1833:1936–1946. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Baj-Krzyworzeka M, Mytar B, Szatanek R,
Surmiak M, Węglarczyk K, Baran J and Siedlar M: Colorectal
cancer-derived microvesicles modulate differentiation of human
monocytes to macrophages. J Transl Med. 14:362016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li Y, Zhao L, Shi B, Ma S, Xu Z, Ge Y, Liu
Y, Zheng D and Shi J: Functions of miR-146a and miR-222 in
tumor-associated macrophages in breast cancer. Sci Rep.
5:186482015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Huber V, Vallacchi V, Fleming V, Hu X,
Cova A, Dugo M, Shahaj E, Sulsenti R, Vergani E, Filipazzi P, et
al: Tumor-derived microRNAs induce myeloid suppressor cells and
predict immunotherapy resistance in melanoma. J Clin Invest.
128:5505–5516. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ren W, Hou J, Yang C, Wang H, Wu S, Wu Y,
Zhao X and Lu C: Extracellular vesicles secreted by hypoxia
pre-challenged mesenchymal stem cells promote non-small cell lung
cancer cell growth and mobility as well as macrophage M2
polarization via miR-21-5p delivery. J Exp Clin Cancer Res.
38:622019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chaudhuri AA, So AY, Sinha N, Gibson WS,
Taganov KD, O’Connell RM and Baltimore D: MicroRNA-125b potentiates
macrophage activation. J Immunol. 187:5062–5068. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ke M, Zhang Z, Cong L, Zhao S, Li Y, Wang
X, Lv Y, Zhu Y and Dong J: MicroRNA-148b-colony-stimulating
factor-1 signaling-induced tumor-associated macrophage infiltration
promotes hepatocellular carcinoma metastasis. Biomed Pharmacother.
120:1095232019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
He M, Xu Z, Ding T, Kuang DM and Zheng L:
MicroRNA-155 regulates inflammatory cytokine production in
tumor-associated macrophages via targeting C/EBPbeta. Cell Mol
Immunol. 6:343–352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zonari E, Pucci F, Saini M, Mazzieri R,
Politi LS, Gentner B and Naldini L: A role for miR-155 in enabling
tumor-infiltrating innate immune cells to mount effective antitumor
responses in mice. Blood. 122:243–252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhao JL, Huang F, He F, Gao CC, Liang SQ,
Ma PF, Dong GY, Han H and Qin HY: Forced activation of notch in
macrophages represses tumor growth by upregulating miR-125a and
disabling tumor-associated macrophages. Cancer Res. 76:1403–1415.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Squadrito ML, Pucci F, Magri L, Moi D,
Gilfillan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L
and De Palma M: miR-511-3p modulates genetic programs of
tumor-associated macrophages. Cell Rep. 1:141–154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fabbri M, Paone A, Calore F, Galli R,
Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, et al:
MicroRNAs bind to Toll-like receptors to induce prometastatic
inflammatory response. Proc Natl Acad Sci USA. 109:E2110–2116.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Frank AC, Ebersberger S, Fink AF, Lampe S,
Weigert A, Schmid T, Ebersberger I, Syed SN and Brüne B: Apoptotic
tumor cell-derived microRNA-375 uses CD36 to alter the
tumor-associated macrophage phenotype. Nat Commun. 10:11352019.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Xu L, Xu W, Wen Z and Xiong S: In situ
prior proliferation of CD4+ CCR6+ regulatory T cells facilitated by
TGF-β secreting DCs is crucial for their enrichment and suppression
in tumor immunity. PLoS One. 6:e202822011. View Article : Google Scholar
|
|
58
|
Yin Y, Cai X, Chen X, Liang H, Zhang Y, Li
J, Wang Z, Chen X, Zhang W, Yokoyama S, et al: Tumor-secreted
miR-214 induces regulatory T cells: A major link between immune
evasion and tumor growth. Cell Res. 24:1164–1180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ye SB, Zhang H, Cai TT, Liu YN, Ni JJ, He
J, Peng JY, Chen QY, Mo HY, Jun-Cui, et al: Exosomal miR-24-3p
impedes T-cell function by targeting FGF11 and serves as a
potential prognostic biomarker for nasopharyngeal carcinoma. J
Pathol. 240:329–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hu Y, Wang C, Li Y, Zhao J, Chen C, Zhou
Y, Tao Y, Guo M, Qin N, Ren T, et al: MiR-21 controls in situ
expansion of CCR6+ regulatory T cells through PTEN/AKT
pathway in breast cancer. Immunol Cell Biol. 93:753–764. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Qin A, Wen Z, Zhou Y, Li Y, Li Y, Luo J,
Ren T and Xu L: MicroRNA-126 regulates the induction and function
of CD4(+) Foxp3(+) regulatory T cells through PI3K/AKT pathway. J
Cell Mol Med. 17:252–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhang M, Gao D, Shi Y, Wang Y, Joshi R, Yu
Q, Liu D, Alotaibi F, Zhang Y, Wang H, et al: miR-149-3p reverses
CD8+ T-cell exhaustion by reducing inhibitory receptors and
promoting cyto-kine secretion in breast cancer cells. Open Biol.
9:1900612019. View Article : Google Scholar
|
|
63
|
Lou Q, Liu R, Yang X, Li W, Huang L, Wei
L, Tan H, Xiang N, Chan K, Chen J and Liu H: miR-448 targets IDO1
and regulates CD8+ T cell response in human colon cancer. J
Immunother Cancer. 7:2102019. View Article : Google Scholar :
|
|
64
|
Mangala LS, Wang H, Jiang D, Wu SY,
Somasunderam A, Volk DE, Lokesh GLR, Li X, Pradeep S, Yang X, et
al: Improving vascular maturation using noncoding RNAs increases
antitumor effect of chemotherapy. JCI Insight. 3:pii: 122387.
2018.PubMed/NCBI
|
|
65
|
Zhang H, Bai M, Deng T, Liu R, Wang X, Qu
Y, Duan J, Zhang L, Ning T, Ge S, et al: Cell-derived microvesicles
mediate the delivery of miR-29a/c to suppress angiogenesis in
gastric carcinoma. Cancer Lett. 375:331–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Di Modica M, Regondi V, Sandri M, Iorio
MV, Zanetti A, Tagliabue E, Casalini P and Triulzi T: Breast
cancer-secreted miR-939 downregulates VE-cadherin and destroys the
barrier function of endothelial monolayers. Cancer Lett.
384:94–100. 2017. View Article : Google Scholar
|
|
67
|
Guan B, Wu K, Zeng J, Xu S, Mu L, Gao Y,
Wang K, Ma Z, Tian J, Shi Q, et al: Tumor-suppressive microRNA-218
inhibits tumor angiogenesis via targeting the mTOR component RICTOR
in prostate cancer. Oncotarget. 8:8162–8172. 2017. View Article : Google Scholar :
|
|
68
|
Dimitrova N, Gocheva V, Bhutkar A, Resnick
R, Jong RM, Miller KM, Bendor J and Jacks T: Stromal expression of
miR-143/145 promotes neoangiogenesis in lung cancer development.
Cancer Discov. 6:188–201. 2016. View Article : Google Scholar :
|
|
69
|
Smits M, Wurdinger T, van het Hof B,
Drexhage JA, Geerts D, Wesseling P, Noske DP, Vandertop WP, de
Vries HE and Reijerkerk A: Myc-associated zinc finger protein (MAZ)
is regulated by miR-125b and mediates VEGF-induced angiogenesis in
glioblastoma. FASEB J. 26:2639–2647. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Fang L, Deng Z, Shatseva T, Yang J, Peng
C, Du WW, Yee AJ, Ang LC, He C, Shan SW and Yang BB: MicroRNA
miR-93 promotes tumor growth and angiogenesis by targeting
integrin-β8. Oncogene. 30:806–821. 2011. View Article : Google Scholar
|
|
71
|
Fang L, Du WW, Yang W, Rutnam ZJ, Peng C,
Li H, O'Malley YQ, Askeland RW, Sugg S, Liu M, et al: MiR-93
enhances angio-genesis and metastasis by targeting LATS2. Cell
Cycle. 11:4352–4365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Szczyrba J, Nolte E, Hart M, Döll C, Wach
S, Taubert H, Keck B, Kremmer E, Stöhr R, Hartmann A, et al:
Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for
microRNAs that are downregulated in prostate carcinoma. Int J
Cancer. 132:775–784. 2013. View Article : Google Scholar
|
|
73
|
Cheng J, Chen Y, Zhao P, Liu X, Dong J, Li
J, Huang C, Wu R and Lv Y: Downregulation of miRNA-638- promotes
angiogenesis and growth of hepatocellular carcinoma by targeting
VEGF. Oncotarget. 7:30702–30711. 2016.PubMed/NCBI
|
|
74
|
Schauer IG, Sood AK, Mok S and Liu J:
Cancer-associated fibroblasts and their putative role in
potentiating the initiation and development of epithelial ovarian
cancer. Neoplasia. 13:393–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Shen Z, Qin X, Yan M, Li R, Chen G, Zhang
J and Chen W: Cancer-associated fibroblasts promote cancer cell
growth through a miR-7-RASSF2-PAR-4 axis in the tumor
microenvi-ronment. Oncotarget. 8:1290–1303. 2017.
|
|
76
|
Wang X, Qin X, Yan M, Shi J, Xu Q, Li Z,
Yang W, Zhang J and Chen W: Loss of exosomal miR-3188 in
cancer-associated fibroblasts contributes to HNC progression. J Exp
Clin Cancer Res. 38:1512019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Biswas SK, Allavena P and Mantovani A:
Tumor-associated macrophages: Functional diversity, clinical
significance, and open questions. Semin Immunopathol. 35:585–600.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
De Palma M and Lewis CE: Macrophage
regulation of tumor responses to anticancer therapies. Cancer Cell.
23:277–286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Epelman S, Lavine KJ and Randolph GJ:
Origin and functions of tissue macrophages. Immunity. 41:21–35.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan
J, Zou Y and Chen S: Macrophage-derived exosomal microRNA-501-3p
promotes progression of pancreatic ductal adenocarcinoma through
the TGFBR3-mediated TGF-β signaling pathway. J Exp Clin Cancer Res.
38:3102019. View Article : Google Scholar
|
|
81
|
Min S, Li L, Zhang M, Zhang Y, Liang X,
Xie Y, He Q, Li Y, Sun J, Liu Q, et al: TGF-β-associated miR-27a
inhibits dendritic cell-mediated differentiation of Th1 and Th17
cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7. Genes Immun.
13:621–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Nguyen DX, Bos PD and Massague J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y,
Li C, Chong M, Ibrahim T, Mercatali L, et al: miR-126 and miR-126*
repress recruitment of mesenchymal stem cells and inflammatory
monocytes to inhibit breast cancer metastasis. Nat Cell Biol.
15:284–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Li BL, Lu W, Qu JJ, Ye L, Du GQ and Wan
XP: Loss of exosomal miR-148b from cancer-associated fibroblasts
promotes endometrial cancer cell invasion and cancer metastasis. J
Cell Physiol. 234:2943–2953. 2019. View Article : Google Scholar
|
|
86
|
Cuiffo BG, Campagne A, Bell GW, Lembo A,
Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, et al:
MSC-regulated microRNAs converge on the transcription factor FOXP2
and promote breast cancer metastasis. Cell Stem Cell. 15:762–774.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhou SL, Hu ZQ, Zhou ZJ, Dai Z, Wang Z,
Cao Y, Fan J, Huang XW and Zhou J: miR-28-5p-IL-34-macrophage
feedback loop modulates hepatocellular carcinoma metastasis.
Hepatology. 63:1560–1575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lou G, Song X, Yang F, Wu S, Wang J, Chen
Z and Liu Y: Exosomes derived from miR-122-modified adipose
tissue-derived MSCs increase chemosensitivity of hepatocellular
carcinoma. J Hematol Oncol. 8:1222015. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wei X, Tang C, Lu X, Liu R, Zhou M, He D,
Zheng D, Sun C and Wu Z: MiR-101 targets DUSP1 to regulate the
TGF-β secretion in sorafenib inhibits macrophage-induced growth of
hepatocar-cinoma. Oncotarget. 6:18389–18405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Tanaka K, Miyata H, Sugimura K, Fukuda S,
Kanemura T, Yamashita K, Miyazaki Y, Takahashi T, Kurokawa Y,
Yamasaki M, et al: miR-27 is associated with chemoresistance in
esophageal cancer through transformation of normal fibroblasts to
cancer-associated fibroblasts. Carcinogenesis. 36:894–903. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Bryant RJ, Pawlowski T, Catto JW, Marsden
G, Vessella RL, Rhees B, Kuslich C, Visakorpi T and Hamdy FC:
Changes in circulating microRNA levels associated with prostate
cancer. Br J Cancer. 106:768–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Lee YS, Lim YS, Lee JC, Wang SG, Park HY,
Kim SY and Lee BJ: Differential expression levels of plasma-derived
miR-146b and miR-155 in papillary thyroid cancer. Oral Oncol.
51:77–83. 2015. View Article : Google Scholar
|
|
94
|
Yi SJ, Liu P, Chen BL, Ou-Yang L, Xiong WM
and Su JP: Circulating miR-31-5p may be a potential diagnostic
biomarker in nasopharyngeal carcinoma. Neoplasma. 66:825–829. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: A new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Hornick NI, Huan J, Doron B, Goloviznina
NA, Lapidus J, Chang BH and Kurre P: Serum exosome MicroRNA as a
minimally-invasive early biomarker of AML. Sci Rep. 5:112952015.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Donahue TR, Nguyen AH, Moughan J, Li L,
Tatishchev S, Toste P and Farrell JJ: Stromal microRNA-21 levels
predict response to 5-fluorouracil in patients with pancreatic
cancer. J Surg Oncol. 110:952–959. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Cubillos-Ruiz JR, Baird JR, Tesone AJ,
Rutkowski MR, Scarlett UK, Camposeco-Jacobs AL, Anadon-Arnillas J,
Harwood NM, Korc M, Fiering SN, et al: Reprogramming
tumor-associated dendritic cells in vivo using miRNA mimetics
triggers protective immunity against ovarian cancer. Cancer Res.
72:1683–1693. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Huang Z, Gan J, Long Z, Guo G, Shi X, Wang
C, Zang Y, Ding Z, Chen J, Zhang J and Dong L: Targeted delivery of
let-7b to reprogramme tumor-associated macrophages and tumor
infiltrating dendritic cells for tumor rejection. Biomaterials.
90:72–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Xi J, Huang Q, Wang L, Ma X, Deng Q, Kumar
M, Zhou Z, Li L, Zeng Z, Young KH, et al: miR-21 depletion in
macrophages promotes tumoricidal polarization and enhances PD-1
immuno-therapy. Oncogene. 37:3151–3165. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Pi J, Tao T, Zhuang T, Sun H, Chen X, Liu
J, Cheng Y, Yu Z, Zhu HH, Gao WQ, et al: A
MicroRNA302-367-Erk1/2-Klf2-S1pr1 pathway prevents tumor growth via
restricting angiogenesis and improving vascular stability. Circ
Res. 120:85–98. 2017. View Article : Google Scholar
|
|
102
|
Schnittert J, Kuninty PR, Bystry TF, Brock
R, Storm G and Prakash J: Anti-microRNA targeting using
peptide-based nano-complexes to inhibit differentiation of human
pancreatic stellate cells. Nanomedicine (Lond). 12:1369–1384. 2017.
View Article : Google Scholar
|
|
103
|
Pecot CV, Calin GA, Coleman RL,
Lopez-Berestein G and Sood AK: RNA interference in the clinic:
Challenges and future directions. Nat Rev Cancer. 11:59–67. 2011.
View Article : Google Scholar :
|
|
104
|
Ling H, Fabbri M and Calin GA: MicroRNAs
and other non-coding RNAs as targets for anticancer drug
development. Nat Rev Drug Discov. 12:847–865. 2013. View Article : Google Scholar : PubMed/NCBI
|
